Angiotensin II antagonism and pre-glomerular arterial wall dimensions in the kidney of the spontaneously hypertensive rat

Clinical and Experimental Hypertension

Volumn 19, Issue 5-6, 1997, Pages 965-979

  Anderson, W P ^a   Kett, M M ^b   Alcorn, D ^b   Bertram, J F ^b  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Angiotensin II receptors; Arcuate artery; Interlobular artery; Stereology; Wall:lumen ratio

Indexed keywords

ENALAPRIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY INTIMA PROLIFERATION; CONFERENCE PAPER; GLOMERULUS CAPILLARY; HYPERTENSION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; RAT; RENAL ARTERY; RENOVASCULAR HYPERTENSION; SPONTANEOUSLY HYPERTENSIVE RAT;

EID: 0030810835     PISSN: 10641963     EISSN: None     Source Type: Journal    
DOI: 10.3109/10641969709083199     Document Type: Conference Paper

References (28)

1. Folkow B, Gothberg G, Lundin S, Ricksten SE. Structural renal vascular changes in renal hypertensive rats (SHR). Acta Physiol Scand. 1977; 101:254-256.
2. Gothberg G, Lundin S, Rickstein SE, Folkow B. Apparent and true vascular resistance to flow in SHR and NCR kidneys is related to the pre/post glomerular resistance rate. Acta Physiol Scand. 1979; 105:282-294.
3. Smeda JS, Lee RMKW, Forrest JB. Structural and reactivity alterations of the renal vasculature of spontaneously hypertensive rats prior to and during established hypertension. Circ Res. 1988; 63:518-533.
4. Kett MM, Alcorn D, Bertram JF, Anderson WP. Enalapril does not prevent renal arterial hypertrophy in spontaneously hypertensive rats. Hypertension. 1995; 25:335-342.
5. Skov K, Mulvany MJ, Korsgaard N. Morphology of renal afferent arterioles in spontaneously hypertensive rats. Hypertension. 1992; 20:821-827.
6. Gattone VH II, Evan AP, Willis LR, Luft FC. Renal afferent arteriole in the spontaneously hypertensive rat. Hypertension. 1983; 5:8-16.
7. Kimura K, Tojo A, Matsuoka H, Sugimoto T. Renal arteriolar diameters in spontaneously hypertensive rats. Hypertension. 1991; 18:101-110.
8. Notoya M, Nakamura M, Mizojiri K. Effects of lisinopril on the structure of renal arterioles. Hypertension. 1996;27:364-370.
9. Folkow B. Kidneys and primary hypertension - initiators, stabilizers or/and victim-aggravators? Blood Pressure. 1994; 3:212-215.
10. Smeda JS, Lee RMKW, Forrest JB. Prenatal and postnatal hydralazine treatment does not prevent renal vessel wall thickening in SHR despite the absence of hypertension. Circ Res. 1988; 63:534-542.
11. Dubey RK, Roy A, Overbeck HW. Culture of renal arteriolar smooth muscle cells: mitogenic responses to angiotensin II. Circ Res. 1992; 71:1143-1152.
12. Johnson RJ, Alpers CE, Yoshimura A, Lombardi D, Pritzl P, Floege J, Schwartz SM. Renal injury from angiotensin II-mediated hypertension. Hypertension. 1992; 19:464-474.
13. Rosenberg ME, Hostetter TH. Effect of angiotensin II and norepinephrine on early growth response genes in the rat kidney. Kidney Int. 1993; 43:601-609.
14. Thybo NK, Korsgaard N, Eriksen S, Christensen KL, Mulvany MJ. Dose-dependent effects of perindopril on blood pressure and small-artery structure. Hypertension. 1994; 23:659-666.
15. Lee RMKW, Berecek KH, Tsoporis J, McKenzie R, Triggle CR. Prevention of hypertension and vascular changes by captopril treatment. Hypertension. 1991; 17:141-150.
16. Harrap SB, Van der Merwe WM, Griffin SA, Macpherson F, Lever AF. Brief antiotensin converting enzyme inhibitor treatment in young spontaneously hypertensive rats reduces blood pressure long-term. Hypertension. 1990; 16:603-614.
17. Gohlke P, Stoll M, Lamberty V, Mattfield T, Mall G, Van Even P, Martorana P, Unger T. Cardiac and vascular effects of chronic angiotensin converting enzyme inhibition at subantihypertensive doses. J Hypertens. 1992; 10:S141-S144.
18. Rizzoni D, Castellano M, Porten E, Bettoni G, Muiesan ML, Cinelli A, Rosei EA. Effects of low and high doses of fosinopril on the structure and function of resistance arteries. Hypertension. 1995; 26:118-123.
19. Skidgel RA, Defendini R, Erdös EG. Angiotensin I converting enzyme and its role in neuropeptide metabolism. In: Neuropeptides and their peptidases. Ed: A J Turner. Ellis Horwood, Chichester, United Kingdom, 1987.
20. 1 antagonism. J Hypertens. 1996; 14:107-113.
21. Gundersen HJG, Bendtsen TF, Korbo L, Marcussen M, Moller A, Nielsen K, Nyengaard JR, Pakkenberg B, Sorensen FB, Vesterby A, West MJ. Some new, simple and efficient stereological methods and their use in pathological research and diagnosis. Acta Pathol Micro Immunol Scand. 1988; 96:379-394.
22. Gundersen HJG, Jensen EV. The efficiency of systematic sampling in stereology and its prediction. J Microsc. 1987; 147:229-263.
23. Kimura K, Nagai R, Sakai T, Aikawa M, Kuro-o M, Kobayashi N, Shirato I, Inagami T, Oshi M, Suzuki N, Oba S, Mise N, Tojo A, Hirata Y, Toto A, Yazaki Y, Omata M. Diversity and variability of smooth muscle phenotypes of renal arterioles as revealed by myosin isoform expression. Kidney Int. 1995; 48:372-382.
24. Folkow B. The Fourth Vohlard Lecture: Cardiovascular structural adaptation; its role in the initiation and maintenance of primary hypertension. Clin Sci Mol Med. 1978; 55:3s-22.
25. Korner P, Angus JA. Structural determinants of vascular resistance properties in hypertension. J Vasc Res. 1992; 29:293-312.
26. Heagerty AM, Aakjaer C, Bund SJ, Korsgaard N, Mulvany MJ. Small artery structure in hypertension: dual processes of remodelling and growth. Hypertension. 1993; 21:391-397.
27. Anderson WP. Is hypertrophy of the walls of pre-glomerular vessels responsible for hypertension in spontaneously hypertensive rats? Blood Pressure. 1994; 3(Supp 5):57-60.
28. Goldblatt H. The renal origin of hypertension. Physiol Rev. 1947; 27:120-162.